世界の眼科用治療薬市場 2021：企業別、地域別、種類・用途別

• 英文タイトル：Global Ophthalmic Therapeutic Drugs Market 2021 by Company, Regions, Type and Application, Forecast to 2026

• レポートコード：GIR-107A12529 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、90ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥515,040 (USD3,480)	▷ お問い合わせ
Multi User	￥772,560 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,030,080 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

当調査資料では、眼科用治療薬のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。眼科用治療薬の種類別市場規模（抗炎症薬、抗感染薬、抗緑内障薬、抗アレルギー薬、抗VEGF薬、その他）、用途別市場規模（病院薬局、オンライン薬局、独立薬局、ドラッグストア）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・眼科用治療薬の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Bayer、Pfizer、Novartis、ALLERGAN、Aerie Pharmaceuticals、Bausch Health、Genentech、Regeneron Pharmaceuticals、Takeda、Santen Pharmaceutical ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：抗炎症薬、抗感染薬、抗緑内障薬、抗アレルギー薬、抗VEGF薬、その他 ・用途別分析2016年-2026年：病院薬局、オンライン薬局、独立薬局、ドラッグストア ・眼科用治療薬の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・眼科用治療薬のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・眼科用治療薬のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・眼科用治療薬の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・眼科用治療薬の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論

The Ophthalmic Therapeutic Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Ophthalmic Therapeutic Drugs size is estimated to be USD 20290 million in 2026 from USD 16710 million in 2020, with a change XX% between 2020 and 2021. The global Ophthalmic Therapeutic Drugs market size is expected to grow at a CAGR of 5.0% for the next five years.

Market segmentation
Ophthalmic Therapeutic Drugs market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
Anti-inflammatory Drugs
Anti-infective Drugs
Anti-glaucoma Drugs
Anti-allergy Drugs
Anti-VEGF Agents
Others

Market segment by Application, can be divided into
Hospital Pharmacies
Online Pharmacies
Independent Pharmacies & Drug Stores

Market segment by players, this report covers
Bayer
Pfizer
Novartis
ALLERGAN
Aerie Pharmaceuticals
Bausch Health
Genentech
Regeneron Pharmaceuticals
Takeda
Santen Pharmaceutical

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Ophthalmic Therapeutic Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Ophthalmic Therapeutic Drugs, with revenue, gross margin and global market share of Ophthalmic Therapeutic Drugs from 2019 to 2021.
Chapter 3, the Ophthalmic Therapeutic Drugs competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by type and application, with revenue and growth rate by type, application, from 2016 to 2026.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2016 to 2021.and Ophthalmic Therapeutic Drugs market forecast, by regions, type and application, with revenue, from 2021 to 2026.
Chapter 11 and 12, to describe Ophthalmic Therapeutic Drugs research findings and conclusion, appendix and data source.

レポート目次

---

1 Market Overview
1.1 Product Overview and Scope of Ophthalmic Therapeutic Drugs
1.2 Classification of Ophthalmic Therapeutic Drugs by Type
1.2.1 Overview: Global Ophthalmic Therapeutic Drugs Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Ophthalmic Therapeutic Drugs Revenue Market Share by Type in 2020
1.2.3 Anti-inflammatory Drugs
1.2.4 Anti-infective Drugs
1.2.5 Anti-glaucoma Drugs
1.2.6 Anti-allergy Drugs
1.2.7 Anti-VEGF Agents
1.2.8 Others
1.3 Global Ophthalmic Therapeutic Drugs Market by Application
1.3.1 Overview: Global Ophthalmic Therapeutic Drugs Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Hospital Pharmacies
1.3.3 Online Pharmacies
1.3.4 Independent Pharmacies & Drug Stores
1.4 Global Ophthalmic Therapeutic Drugs Market Size & Forecast
1.5 Global Ophthalmic Therapeutic Drugs Market Size and Forecast by Region
1.5.1 Global Ophthalmic Therapeutic Drugs Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Ophthalmic Therapeutic Drugs Market Size by Region, (2016-2021)
1.5.3 North America Ophthalmic Therapeutic Drugs Market Size and Prospect (2016-2026)
1.5.4 Europe Ophthalmic Therapeutic Drugs Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Ophthalmic Therapeutic Drugs Market Size and Prospect (2016-2026)
1.5.6 South America Ophthalmic Therapeutic Drugs Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Ophthalmic Therapeutic Drugs Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Ophthalmic Therapeutic Drugs Market Drivers
1.6.2 Ophthalmic Therapeutic Drugs Market Restraints
1.6.3 Ophthalmic Therapeutic Drugs Trends Analysis
2 Company Profiles
2.1 Bayer
2.1.1 Bayer Details
2.1.2 Bayer Major Business
2.1.3 Bayer Ophthalmic Therapeutic Drugs Product and Solutions
2.1.4 Bayer Ophthalmic Therapeutic Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Bayer Recent Developments and Future Plans
2.2 Pfizer
2.2.1 Pfizer Details
2.2.2 Pfizer Major Business
2.2.3 Pfizer Ophthalmic Therapeutic Drugs Product and Solutions
2.2.4 Pfizer Ophthalmic Therapeutic Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Pfizer Recent Developments and Future Plans
2.3 Novartis
2.3.1 Novartis Details
2.3.2 Novartis Major Business
2.3.3 Novartis Ophthalmic Therapeutic Drugs Product and Solutions
2.3.4 Novartis Ophthalmic Therapeutic Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Novartis Recent Developments and Future Plans
2.4 ALLERGAN
2.4.1 ALLERGAN Details
2.4.2 ALLERGAN Major Business
2.4.3 ALLERGAN Ophthalmic Therapeutic Drugs Product and Solutions
2.4.4 ALLERGAN Ophthalmic Therapeutic Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 ALLERGAN Recent Developments and Future Plans
2.5 Aerie Pharmaceuticals
2.5.1 Aerie Pharmaceuticals Details
2.5.2 Aerie Pharmaceuticals Major Business
2.5.3 Aerie Pharmaceuticals Ophthalmic Therapeutic Drugs Product and Solutions
2.5.4 Aerie Pharmaceuticals Ophthalmic Therapeutic Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Aerie Pharmaceuticals Recent Developments and Future Plans
2.6 Bausch Health
2.6.1 Bausch Health Details
2.6.2 Bausch Health Major Business
2.6.3 Bausch Health Ophthalmic Therapeutic Drugs Product and Solutions
2.6.4 Bausch Health Ophthalmic Therapeutic Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Bausch Health Recent Developments and Future Plans
2.7 Genentech
2.7.1 Genentech Details
2.7.2 Genentech Major Business
2.7.3 Genentech Ophthalmic Therapeutic Drugs Product and Solutions
2.7.4 Genentech Ophthalmic Therapeutic Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Genentech Recent Developments and Future Plans
2.8 Regeneron Pharmaceuticals
2.8.1 Regeneron Pharmaceuticals Details
2.8.2 Regeneron Pharmaceuticals Major Business
2.8.3 Regeneron Pharmaceuticals Ophthalmic Therapeutic Drugs Product and Solutions
2.8.4 Regeneron Pharmaceuticals Ophthalmic Therapeutic Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Regeneron Pharmaceuticals Recent Developments and Future Plans
2.9 Takeda
2.9.1 Takeda Details
2.9.2 Takeda Major Business
2.9.3 Takeda Ophthalmic Therapeutic Drugs Product and Solutions
2.9.4 Takeda Ophthalmic Therapeutic Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Takeda Recent Developments and Future Plans
2.10 Santen Pharmaceutical
2.10.1 Santen Pharmaceutical Details
2.10.2 Santen Pharmaceutical Major Business
2.10.3 Santen Pharmaceutical Ophthalmic Therapeutic Drugs Product and Solutions
2.10.4 Santen Pharmaceutical Ophthalmic Therapeutic Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 Santen Pharmaceutical Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Ophthalmic Therapeutic Drugs Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Ophthalmic Therapeutic Drugs Players Market Share
3.2.2 Top 10 Ophthalmic Therapeutic Drugs Players Market Share
3.2.3 Market Competition Trend
3.3 Ophthalmic Therapeutic Drugs Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Ophthalmic Therapeutic Drugs Revenue and Market Share by Type (2016-2021)
4.2 Global Ophthalmic Therapeutic Drugs Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Ophthalmic Therapeutic Drugs Revenue Market Share by Application (2016-2021)
5.2 Ophthalmic Therapeutic Drugs Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Ophthalmic Therapeutic Drugs Revenue by Type (2016-2026)
6.2 North America Ophthalmic Therapeutic Drugs Revenue by Application (2016-2026)
6.3 North America Ophthalmic Therapeutic Drugs Market Size by Country
6.3.1 North America Ophthalmic Therapeutic Drugs Revenue by Country (2016-2026)
6.3.2 United States Ophthalmic Therapeutic Drugs Market Size and Forecast (2016-2026)
6.3.3 Canada Ophthalmic Therapeutic Drugs Market Size and Forecast (2016-2026)
6.3.4 Mexico Ophthalmic Therapeutic Drugs Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Ophthalmic Therapeutic Drugs Revenue by Type (2016-2026)
7.2 Europe Ophthalmic Therapeutic Drugs Revenue by Application (2016-2026)
7.3 Europe Ophthalmic Therapeutic Drugs Market Size by Country
7.3.1 Europe Ophthalmic Therapeutic Drugs Revenue by Country (2016-2026)
7.3.2 Germany Ophthalmic Therapeutic Drugs Market Size and Forecast (2016-2026)
7.3.3 France Ophthalmic Therapeutic Drugs Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Ophthalmic Therapeutic Drugs Market Size and Forecast (2016-2026)
7.3.5 Russia Ophthalmic Therapeutic Drugs Market Size and Forecast (2016-2026)
7.3.6 Italy Ophthalmic Therapeutic Drugs Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Ophthalmic Therapeutic Drugs Revenue by Type (2016-2026)
8.2 Asia-Pacific Ophthalmic Therapeutic Drugs Revenue by Application (2016-2026)
8.3 Asia-Pacific Ophthalmic Therapeutic Drugs Market Size by Region
8.3.1 Asia-Pacific Ophthalmic Therapeutic Drugs Revenue by Region (2016-2026)
8.3.2 China Ophthalmic Therapeutic Drugs Market Size and Forecast (2016-2026)
8.3.3 Japan Ophthalmic Therapeutic Drugs Market Size and Forecast (2016-2026)
8.3.4 South Korea Ophthalmic Therapeutic Drugs Market Size and Forecast (2016-2026)
8.3.5 India Ophthalmic Therapeutic Drugs Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Ophthalmic Therapeutic Drugs Market Size and Forecast (2016-2026)
8.3.7 Australia Ophthalmic Therapeutic Drugs Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Ophthalmic Therapeutic Drugs Revenue by Type (2016-2026)
9.2 South America Ophthalmic Therapeutic Drugs Revenue by Application (2016-2026)
9.3 South America Ophthalmic Therapeutic Drugs Market Size by Country
9.3.1 South America Ophthalmic Therapeutic Drugs Revenue by Country (2016-2026)
9.3.2 Brazil Ophthalmic Therapeutic Drugs Market Size and Forecast (2016-2026)
9.3.3 Argentina Ophthalmic Therapeutic Drugs Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Ophthalmic Therapeutic Drugs Revenue by Type (2016-2026)
10.2 Middle East & Africa Ophthalmic Therapeutic Drugs Revenue by Application (2016-2026)
10.3 Middle East & Africa Ophthalmic Therapeutic Drugs Market Size by Country
10.3.1 Middle East & Africa Ophthalmic Therapeutic Drugs Revenue by Country (2016-2026)
10.3.2 Turkey Ophthalmic Therapeutic Drugs Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Ophthalmic Therapeutic Drugs Market Size and Forecast (2016-2026)
10.3.4 UAE Ophthalmic Therapeutic Drugs Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer

List of Tables
Table 1. Global Ophthalmic Therapeutic Drugs Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Ophthalmic Therapeutic Drugs Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Ophthalmic Therapeutic Drugs Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Ophthalmic Therapeutic Drugs Revenue (USD Million) by Region (2016-2021)
Table 5. Global Ophthalmic Therapeutic Drugs Revenue Market Share by Region (2021-2026)
Table 6. Bayer Corporate Information, Head Office, and Major Competitors
Table 7. Bayer Major Business
Table 8. Bayer Ophthalmic Therapeutic Drugs Product and Solutions
Table 9. Bayer Ophthalmic Therapeutic Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Pfizer Corporate Information, Head Office, and Major Competitors
Table 11. Pfizer Major Business
Table 12. Pfizer Ophthalmic Therapeutic Drugs Product and Solutions
Table 13. Pfizer Ophthalmic Therapeutic Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Novartis Corporate Information, Head Office, and Major Competitors
Table 15. Novartis Major Business
Table 16. Novartis Ophthalmic Therapeutic Drugs Product and Solutions
Table 17. Novartis Ophthalmic Therapeutic Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. ALLERGAN Corporate Information, Head Office, and Major Competitors
Table 19. ALLERGAN Major Business
Table 20. ALLERGAN Ophthalmic Therapeutic Drugs Product and Solutions
Table 21. ALLERGAN Ophthalmic Therapeutic Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Aerie Pharmaceuticals Corporate Information, Head Office, and Major Competitors
Table 23. Aerie Pharmaceuticals Major Business
Table 24. Aerie Pharmaceuticals Ophthalmic Therapeutic Drugs Product and Solutions
Table 25. Aerie Pharmaceuticals Ophthalmic Therapeutic Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Bausch Health Corporate Information, Head Office, and Major Competitors
Table 27. Bausch Health Major Business
Table 28. Bausch Health Ophthalmic Therapeutic Drugs Product and Solutions
Table 29. Bausch Health Ophthalmic Therapeutic Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Genentech Corporate Information, Head Office, and Major Competitors
Table 31. Genentech Major Business
Table 32. Genentech Ophthalmic Therapeutic Drugs Product and Solutions
Table 33. Genentech Ophthalmic Therapeutic Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Regeneron Pharmaceuticals Corporate Information, Head Office, and Major Competitors
Table 35. Regeneron Pharmaceuticals Major Business
Table 36. Regeneron Pharmaceuticals Ophthalmic Therapeutic Drugs Product and Solutions
Table 37. Regeneron Pharmaceuticals Ophthalmic Therapeutic Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Takeda Corporate Information, Head Office, and Major Competitors
Table 39. Takeda Major Business
Table 40. Takeda Ophthalmic Therapeutic Drugs Product and Solutions
Table 41. Takeda Ophthalmic Therapeutic Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Santen Pharmaceutical Corporate Information, Head Office, and Major Competitors
Table 43. Santen Pharmaceutical Major Business
Table 44. Santen Pharmaceutical Ophthalmic Therapeutic Drugs Product and Solutions
Table 45. Santen Pharmaceutical Ophthalmic Therapeutic Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. Global Ophthalmic Therapeutic Drugs Revenue (USD Million) by Players (2019-2021)
Table 47. Global Ophthalmic Therapeutic Drugs Revenue Share by Players (2019-2021)
Table 48. Breakdown of Ophthalmic Therapeutic Drugs by Company Type (Tier 1, Tier 2 and Tier 3)
Table 49. Ophthalmic Therapeutic Drugs Players Head Office, Products and Services Provided
Table 50. Ophthalmic Therapeutic Drugs Mergers & Acquisitions in the Past Five Years
Table 51. Ophthalmic Therapeutic Drugs New Entrants and Expansion Plans
Table 52. Global Ophthalmic Therapeutic Drugs Revenue (USD Million) by Type (2016-2021)
Table 53. Global Ophthalmic Therapeutic Drugs Revenue Share by Type (2016-2021)
Table 54. Global Ophthalmic Therapeutic Drugs Revenue Forecast by Type (2021-2026)
Table 55. Global Ophthalmic Therapeutic Drugs Revenue by Application (2016-2021)
Table 56. Global Ophthalmic Therapeutic Drugs Revenue Forecast by Application (2021-2026)
Table 57. North America Ophthalmic Therapeutic Drugs Revenue by Type (2016-2021) & (USD Million)
Table 58. North America Ophthalmic Therapeutic Drugs Revenue by Type (2021-2026) & (USD Million)
Table 59. North America Ophthalmic Therapeutic Drugs Revenue by Application (2016-2021) & (USD Million)
Table 60. North America Ophthalmic Therapeutic Drugs Revenue by Application (2021-2026) & (USD Million)
Table 61. North America Ophthalmic Therapeutic Drugs Revenue by Country (2016-2021) & (USD Million)
Table 62. North America Ophthalmic Therapeutic Drugs Revenue by Country (2021-2026) & (USD Million)
Table 63. Europe Ophthalmic Therapeutic Drugs Revenue by Type (2016-2021) & (USD Million)
Table 64. Europe Ophthalmic Therapeutic Drugs Revenue by Type (2021-2026) & (USD Million)
Table 65. Europe Ophthalmic Therapeutic Drugs Revenue by Application (2016-2021) & (USD Million)
Table 66. Europe Ophthalmic Therapeutic Drugs Revenue by Application (2021-2026) & (USD Million)
Table 67. Europe Ophthalmic Therapeutic Drugs Revenue by Country (2016-2021) & (USD Million)
Table 68. Europe Ophthalmic Therapeutic Drugs Revenue by Country (2021-2026) & (USD Million)
Table 69. Asia-Pacific Ophthalmic Therapeutic Drugs Revenue by Type (2016-2021) & (USD Million)
Table 70. Asia-Pacific Ophthalmic Therapeutic Drugs Revenue by Type (2021-2026) & (USD Million)
Table 71. Asia-Pacific Ophthalmic Therapeutic Drugs Revenue by Application (2016-2021) & (USD Million)
Table 72. Asia-Pacific Ophthalmic Therapeutic Drugs Revenue by Application (2021-2026) & (USD Million)
Table 73. Asia-Pacific Ophthalmic Therapeutic Drugs Revenue by Region (2016-2021) & (USD Million)
Table 74. Asia-Pacific Ophthalmic Therapeutic Drugs Revenue by Region (2021-2026) & (USD Million)
Table 75. South America Ophthalmic Therapeutic Drugs Revenue by Type (2016-2021) & (USD Million)
Table 76. South America Ophthalmic Therapeutic Drugs Revenue by Type (2021-2026) & (USD Million)
Table 77. South America Ophthalmic Therapeutic Drugs Revenue by Application (2016-2021) & (USD Million)
Table 78. South America Ophthalmic Therapeutic Drugs Revenue by Application (2021-2026) & (USD Million)
Table 79. South America Ophthalmic Therapeutic Drugs Revenue by Country (2016-2021) & (USD Million)
Table 80. South America Ophthalmic Therapeutic Drugs Revenue by Country (2021-2026) & (USD Million)
Table 81. Middle East & Africa Ophthalmic Therapeutic Drugs Revenue by Type (2016-2021) & (USD Million)
Table 82. Middle East & Africa Ophthalmic Therapeutic Drugs Revenue by Type (2021-2026) & (USD Million)
Table 83. Middle East & Africa Ophthalmic Therapeutic Drugs Revenue by Application (2016-2021) & (USD Million)
Table 84. Middle East & Africa Ophthalmic Therapeutic Drugs Revenue by Application (2021-2026) & (USD Million)
Table 85. Middle East & Africa Ophthalmic Therapeutic Drugs Revenue by Country (2016-2021) & (USD Million)
Table 86. Middle East & Africa Ophthalmic Therapeutic Drugs Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Ophthalmic Therapeutic Drugs Picture
Figure 2. Global Ophthalmic Therapeutic Drugs Revenue Market Share by Type in 2020
Figure 3. Anti-inflammatory Drugs
Figure 4. Anti-infective Drugs
Figure 5. Anti-glaucoma Drugs
Figure 6. Anti-allergy Drugs
Figure 7. Anti-VEGF Agents
Figure 8. Others
Figure 9. Ophthalmic Therapeutic Drugs Revenue Market Share by Application in 2020
Figure 10. Hospital Pharmacies Picture
Figure 11. Online Pharmacies Picture
Figure 12. Independent Pharmacies & Drug Stores Picture
Figure 13. Global Ophthalmic Therapeutic Drugs Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 14. Global Ophthalmic Therapeutic Drugs Revenue and Forecast (2016-2026) & (USD Million)
Figure 15. Global Ophthalmic Therapeutic Drugs Revenue Market Share by Region (2016-2026)
Figure 16. Global Ophthalmic Therapeutic Drugs Revenue Market Share by Region in 2020
Figure 17. North America Ophthalmic Therapeutic Drugs Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. Europe Ophthalmic Therapeutic Drugs Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. Asia-Pacific Ophthalmic Therapeutic Drugs Revenue (USD Million) and Growth Rate (2016-2026)
Figure 20. South America Ophthalmic Therapeutic Drugs Revenue (USD Million) and Growth Rate (2016-2026)
Figure 21. Middle East and Africa Ophthalmic Therapeutic Drugs Revenue (USD Million) and Growth Rate (2016-2026)
Figure 22. Ophthalmic Therapeutic Drugs Market Drivers
Figure 23. Ophthalmic Therapeutic Drugs Market Restraints
Figure 24. Ophthalmic Therapeutic Drugs Market Trends
Figure 25. Bayer Recent Developments and Future Plans
Figure 26. Pfizer Recent Developments and Future Plans
Figure 27. Novartis Recent Developments and Future Plans
Figure 28. ALLERGAN Recent Developments and Future Plans
Figure 29. Aerie Pharmaceuticals Recent Developments and Future Plans
Figure 30. Bausch Health Recent Developments and Future Plans
Figure 31. Genentech Recent Developments and Future Plans
Figure 32. Regeneron Pharmaceuticals Recent Developments and Future Plans
Figure 33. Takeda Recent Developments and Future Plans
Figure 34. Santen Pharmaceutical Recent Developments and Future Plans
Figure 35. Global Ophthalmic Therapeutic Drugs Revenue Share by Players in 2020
Figure 36. Ophthalmic Therapeutic Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 37. Global Top 3 Players Ophthalmic Therapeutic Drugs Revenue Market Share in 2020
Figure 38. Global Top 10 Players Ophthalmic Therapeutic Drugs Revenue Market Share in 2020
Figure 39. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 40. Global Ophthalmic Therapeutic Drugs Revenue Share by Type in 2020
Figure 41. Global Ophthalmic Therapeutic Drugs Market Share Forecast by Type (2021-2026)
Figure 42. Global Ophthalmic Therapeutic Drugs Revenue Share by Application in 2020
Figure 43. Global Ophthalmic Therapeutic Drugs Market Share Forecast by Application (2021-2026)
Figure 44. North America Ophthalmic Therapeutic Drugs Sales Market Share by Type (2016-2026)
Figure 45. North America Ophthalmic Therapeutic Drugs Sales Market Share by Application (2016-2026)
Figure 46. North America Ophthalmic Therapeutic Drugs Revenue Market Share by Country (2016-2026)
Figure 47. United States Ophthalmic Therapeutic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. Canada Ophthalmic Therapeutic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. Mexico Ophthalmic Therapeutic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. Europe Ophthalmic Therapeutic Drugs Sales Market Share by Type (2016-2026)
Figure 51. Europe Ophthalmic Therapeutic Drugs Sales Market Share by Application (2016-2026)
Figure 52. Europe Ophthalmic Therapeutic Drugs Revenue Market Share by Country (2016-2026)
Figure 53. Germany Ophthalmic Therapeutic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. France Ophthalmic Therapeutic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. United Kingdom Ophthalmic Therapeutic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Russia Ophthalmic Therapeutic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Italy Ophthalmic Therapeutic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Asia-Pacific Ophthalmic Therapeutic Drugs Sales Market Share by Type (2016-2026)
Figure 59. Asia-Pacific Ophthalmic Therapeutic Drugs Sales Market Share by Application (2016-2026)
Figure 60. Asia-Pacific Ophthalmic Therapeutic Drugs Revenue Market Share by Region (2016-2026)
Figure 61. China Ophthalmic Therapeutic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Japan Ophthalmic Therapeutic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. South Korea Ophthalmic Therapeutic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. India Ophthalmic Therapeutic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. Southeast Asia Ophthalmic Therapeutic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. Australia Ophthalmic Therapeutic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. South America Ophthalmic Therapeutic Drugs Sales Market Share by Type (2016-2026)
Figure 68. South America Ophthalmic Therapeutic Drugs Sales Market Share by Application (2016-2026)
Figure 69. South America Ophthalmic Therapeutic Drugs Revenue Market Share by Country (2016-2026)
Figure 70. Brazil Ophthalmic Therapeutic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. Argentina Ophthalmic Therapeutic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. Middle East and Africa Ophthalmic Therapeutic Drugs Sales Market Share by Type (2016-2026)
Figure 73. Middle East and Africa Ophthalmic Therapeutic Drugs Sales Market Share by Application (2016-2026)
Figure 74. Middle East and Africa Ophthalmic Therapeutic Drugs Revenue Market Share by Country (2016-2026)
Figure 75. Turkey Ophthalmic Therapeutic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. Saudi Arabia Ophthalmic Therapeutic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 77. UAE Ophthalmic Therapeutic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 78. Methodology
Figure 79. Research Process and Data Source

---